Skip to Main Content Area
Home

User login

Login using social networks

  • Create new account
  • Request new password
Home

clinical stage biotechnology

ATHX Athersys Initiated Overweight At Piper Jaffray ($1.67)

Athersys (NASDAQ: ATHX) initiated overweight at Piper Jaffray ($1.67).

  • Athersys
  • [+]
  • clinical stage
  • [+]
  • clinical stage biotechnology
  • [+]
  • inflammatory bowel disease
  • [+]
  • Medicine
  • [+]
  • Piper Jaffray
  • [+]
  • stroke
  • [+]
  • Read more
Syndicate content
  • Terms & Conditions
  • Privacy Policy
  • Cision